Russia has no plans to introduce ban on drug imports

14 October 2015

Russia has no plans to introduce any bans and restrictions on the imports of drugs from abroad, according to recent statements of Russia’s President Vladimir Putin.

However, according to him, by 2018, up to 90% of drugs, presented in Russia, should be produced locally, reports The Pharma Letter’s local correspondent.

Mr Putin comments: "Importing of pharmaceutical substances, with the aim of their further bottling within the country, has nothing to do with full-scale pharmaceutical production. Our main goal is creating conditions for the establishment of production of not only competitive generics, but also original drugs in Russia.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical